Crossmark

Practical aspects of biological throught levels and antidrug antibodies in rheumatoid arthritis and spondyloarthritis

Crossref DOI link: https://doi.org/10.1016/j.reumae.2018.09.013

Published Print: 2020-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Rosas, José

Martín-López, María

Otón, Teresa

Balsa, Alejandro

Calvo-Alén, Jaime

Sanmartí, Raimon

Tornero, Jesús

Carmona, Loreto
Funding

Funding for this research was provided by:

Grifols
License Information

Text and Data Mining valid from 2020-09-01
More Information

This article is maintained by: Elsevier

Article Title: Practical aspects of biological throught levels and antidrug antibodies in rheumatoid arthritis and spondyloarthritis

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2018.09.013

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2018.09.006

Content Type: article

Copyright: © 2018 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.